
Is the Use of Cannabis during Pregnancy a Risk Factor for Autism?
Publication year - 2020
Publication title -
advances in neurology and neuroscience
Language(s) - English
Resource type - Journals
ISSN - 2690-909X
DOI - 10.33140/an.03.01.03
Subject(s) - endocannabinoid system , autism , cannabis , autism spectrum disorder , cannabinoid receptor , pregnancy , psychology , cognition , cannabinoid , psychiatry , clinical psychology , medicine , neuroscience , receptor , biology , genetics , agonist
The use of marijuana by healthy adults is commonly viewed as having limited adverse health effects; however,its potential risks for fetal developmental abnormalities when used during pregnancy have not been thoroughlyevaluated. Marijuana is known to bind to endogenous cannabinoid receptors and exert physiological effects similar toendogenous cannabinoids. The endocannabinoid system is involved in cognition, behavioral, and emotional regulation.Autism Spectrum Disorder is associated with mild to severe cognitive, social and behavioral impairments; moreover,impairments in the endocannabinoid system have been identified in individuals with this disorder. It is, therefore,possible that marijuana use during pregnancy may cause the overexcitation of the endocannabinoid system duringearly brain development to make the fetus at risk for autism spectrum disorder. The present study aims to explore theeffects of prenatal marijuana exposure on the endocannabinoid system, and to present a model of how this interactionmay increase risk of developing autism spectrum disorder.